Skip to content
★ Sign in to follow
MS

Matthew Sydney

Executive
Total declarations
7
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (3 ops.)
€1.9M

Latest filing published 03 Nov 2016 for Healthequity, INC., €32k.

Insider track record

Disclosed buys
0
Disclosed sells
3
Signal history

Matthew Sydney: trading record in brief

Matthew Sydney is a declared insider of Healthequity, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 11 November 2015 to 1 November 2016, the count stands at 7 filings.

The open-market record consists of 3 sales worth €1.9M, with no purchase. Other entries cover 4 option exercises. So far in 2016, the count stands at no purchases and 2 sales.

The latest filing, published on 3 November 2016, reports an option exercise of €32k in Healthequity, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Matthew Sydney

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations7 total
  • ◇
    Exec VP, Sales & MarketingExecutivesHealthequity, Inc.
    35,000 USD11SEC
    2,500 shares@ US$14.002.9% of flowCommon StockSEC:0001140361-16-084703:0
  • ◇
    Exec VP, Sales & MarketingExecutivesHealthequity, Inc.
    102,000 USD12SEC
    5,000 shares@ US$20.408.4% of flowCommon StockSEC:0001140361-16-084703:1
  • ◇
    Exec VP, Sales & MarketingExecutivesHealthequity, Inc.
    4,000 USD11SEC
    5,000 shares@ US$0.800.3% of flowCommon StockSEC:0001140361-16-084703:2
  • ▼
    Exec VP, Sales & MarketingExecutivesHealthequity, Inc.
    800,340 USD36SEC
    24,621 shares@ US$32.506466.2% of flowCommon StockSEC:0001140361-16-084703:4
  • ▼
    Exec VP, Sales & MarketingExecutivesHealthequity, Inc.
    12,607 USD29SEC
    379 shares@ US$33.2651.0% of flowCommon StockSEC:0001140361-16-084703:5
  • ◇
    Exec VP, Sales & MarketingExecutivesHealthequity, Inc.
    255,000 USD13SEC
    12,500 shares@ US$20.4021.1% of flowCommon StockSEC:0001140361-16-084703:3
  • ▼
    Exec VP, Sales & MarketingExecutivesHealthequity, Inc.
    1M USD0SEC
    35,000 shares@ US$35.00Common StockSEC:0001140361-15-041266:0

7 of 7 declarations